Publications, 2004
Department of Oncology, Lund University Hospital, Lund
1. Akervall J., Guo X., Qian C. N., Schoumans J., Leeser B., Kort E., Cole A., Resau J.,
Bradford C., Carey T., Wennerberg J., Anderson H., Tennvall J. and Teh B. T. Genetic
and expression profiles of squamous cell carcinoma of the head and neck correlate with
cisplatin sensitivity and resistance in cell lines and patients. Clin Cancer Res
2004;10(24):8204-13.
2. Bengtsson H., Jonsson G. and Vallon-Christersson J. Calibration and assessment of
channel-specific biases in microarray data with extended dynamical range. BMC
Bioinformatics 2004;5(1):177.
3. Bjorck E., Ek S., Landgren O., Jerkeman M., Ehinger M., Bjorkholm M., Borrebaeck C.
A., Porwit-Macdonald A. and Nordenskjold M. High expression of cyclin B1 predicts a
favorable outcome of patients with follicular lymphoma. Blood 2004.
4. Brun E., Tennvall J., Baldetorp B., Kjellen E., Fallenius G. and Wennerberg J. DNA
ploidy, S-phase fraction and associations with 2-18F-Fluoro-Deoxy-2D-gluose positron
emission tomography findings before and during therapy of head and neck squamous cell
carcinoma. Acta Otolaryngologica 2004;124:1-8.
5. Di Fiore F., Charbonnier F., Martin C., Frerot S., Olschwang S., Wang Q., Boisson C.,
Buisine M. P., Nilbert M., Lindblom A. and Frebourg T. Screening for genomic
rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. J
Med Genet 2004;41(1):18-20.
6. Dryver E., Brandt L., Kauppinen T. and Olsson H. Occupational exposures and nonHodgkin's lymphoma in Southern Sweden. Int J Occup Environ Health 2004;10(1):1321.
7. Eberhard J., Stahl O., Giwercman Y., Cwikiel M., Cavallin-Stahl E., Lundin K. B.,
Flodgren P. and Giwercman A. Impact of therapy and androgen receptor polymorphism
on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study.
Hum Reprod 2004;19(6):1418-25.
8. Eden P., Ritz C., Rose C., Ferno M. and Peterson C. "Good Old" clinical markers have
similar power in breast cancer prognosis as microarray gene expression profilers. Eur J
Cancer 2004;40(12):1837-41.
9. Engellau J., Anderson H., Rydholm A., Bauer H. C., Hall K. S., Gustafson P., Akerman
M., Meis-Kindblom J., Alvegard T. A. and Nilbert M. Time dependence of prognostic
factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338
malignant fibrous histiocytomas. Cancer 2004;100(10):2233-9.
10. Engellau J., Persson A., Bendahl P. O., Akerman M., Domanski H. A., Bjerkehagen B.,
Lilleng P., Weide J., Rydholm A., Alvegard T. A. and Nilbert M. Expression profiling
using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic
value of Ki-67. Virchows Arch 2004;445(3):224-30.
1
11. Ericson K., Nilbert M., Bladstrom A., Anderson H., Olsson H. and Planck M. Familial
risk of tumors associated with hereditary non-polyposis colorectal cancer: a Swedish
population-based study. Scand J Gastroenterol 2004;39(12):1259-1265.
12. Ericson K., Engellau J., Persson A., Lindblom A., Domanski H., Akerman M. and Nilbert
M. Immunohistochemical loss of the DNA mismatch repair proteins MSH2 and MSH6 in
malignant fibrous histocytomas. Sarcoma 2004;8(4):123-127.
13. Fernebro E., Bendahl P. O., Dictor M., Persson A., Ferno M. and Nilbert M.
Immunohistochemical patterns in rectal cancer: Application of tissue microarray with
prognostic correlations. Int J Cancer 2004;111(6):921-8.
14. Ferreri A. J., Campo E., Ambrosetti A., Ilariucci F., Seymour J. F., Willemze R., Arrigoni
G., Rossi G., Lopez-Guillermo A., Berti E., Eriksson M., Federico M., Cortelazzo S.,
Govi S., Frungillo N., Dell'Oro S., Lestani M., Asioli S., Pedrinis E., Ungari M., Motta T.,
Rossi R., Artusi T., Iuzzolino P., Zucca E., Cavalli F. and Ponzoni M. Anthracyclinebased chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol
2004;15(8):1215-21.
15. Gadjieva R., Axelsson E., Olsson U., Vallon-Christersson J. and Hansson M. Nonsensemediated mRNA decay in barley mutants allows the cloning of mutated genes by a
microarray approach. Plant Physiol Biochem 2004;42(7-8):681-5.
16. Giwercman A., Lundin K. B., Eberhard J., Stahl O., Cwikiel M., Cavallin-Stahl E. and
Giwercman Y. L. Linkage between androgen receptor gene CAG trinucleotide repeat
length and testicular germ cell cancer histological type and clinical stage. Eur J Cancer
2004;40(14):2152-8.
17. Gruvberger-Saal S. K., Eden P., Ringner M., Baldetorp B., Chebil G., Borg A., Ferno M.,
Peterson C. and Meltzer P. S. Predicting continuous values of prognostic markers in breast
cancer from microarray gene expression profiles. Mol Cancer Ther 2004;3(2):161-8.
18. Guenel P., Cyr D., Sabroe S., Lynge E., Merletti F., Ahrens W., Baumgardt-Elms C.,
Menegoz F., Olsson H., Paulsen S., Simonato L. and Wingren G. Alcohol drinking may
increase risk of breast cancer in men: a European population-based case-control study.
Cancer Causes Control 2004;15(6):571-80.
19. Hakansson P., Lassen C., Olofsson T., Baldetorp B., Karlsson A., Gullberg U. and
Fioretos T. Establishment and phenotypic characterization of human U937 cells with
inducible P210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a).
Leukemia 2004.
20. Halvarsson B., Lindblom A., Rambech E., Lagerstedt K. and Nilbert M. Microsatellite
instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis
colorectal cancer? Virchows Arch 2004;444(2):135-41.
21. Hansen S., Sorensen F. B., Vach W., Grabau D. A., Bak M. and Rose C. Microvessel
density compared with the Chalkley count in a prognostic study of angiogenesis in breast
cancer patients. Histopathology 2004;44(5):428-36.
2
22. Hardell L., Malmqvist N., Ohlson C. G., Westberg H. and Eriksson M. Testicular cancer
and occupational exposure to polyvinyl chloride plastics: a case-control study. Int J
Cancer 2004;109(3):425-9.
23. Hardell L., van Bavel B., Lindstrom G., Carlberg M., Eriksson M., Dreifaldt A. C.,
Wijkstrom H., Starkhammar H., Hallquist A. and Kolmert T. Concentrations of
polychlorinated biphenyls in blood and the risk for testical cancer. Int J Androl 2004;In
press.
24. Hardell L., Hallquist A., Hansson Mild K., Carlberg M., Gertzen H., Schildt E. B. and
Dahlqvist A. No association between the use of cellular or cordless telephones and
salivary gland tumours. Occup Environ Med 2004;61(8):675-9.
25. Henriksson K., Olsson H. and Kristoffersson U. The need for oncogenetic counselling.
Ten years' experience of a regional oncogenetic clinic. Acta Oncol 2004;43(7):637-49.
26. Hogberg T., Fredstorp-Lidebring M., Alm P., Baldetorp B., Larsson G., Ottosen C.,
Svanberg L. and Lindahl B. A prospective population-based management program
including primary surgery and postoperative risk assessment by means of DNA ploidy and
histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with
FIGO stage I-II endometrial cancer. Int J Gynecol Cancer 2004;14(3):437-50.
27. Holten-Andersen M., Christensen I. J., Nilbert M., Bendahl P. O., Nielsen H. J., Brunner
N. and Fernebro E. Association between preoperative plasma levels of tissue inhibitor of
metalloproteinases 1 and rectal cancer patient survival. a validation study. Eur J Cancer
2004;40(1):64-72.
28. Jerkeman M., Anderson H., Dictor M., Kvaloy S., Akerman M. and Cavallin-Stahl E.
Assessment of biological prognostic factors provides clinically relevant information in
patients with diffuse large B-cell lymphoma-a Nordic Lymphoma Group study. Ann
Hematol 2004.
29. Jerkeman M., Leppa S., Kvaloy S. and Holte H. ICE (ifosfamide, carboplatin, etoposide)
as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma-the Nordic Lymphoma Group experience. Eur J Haematol 2004;73(3):179-82.
30. Jernstrom H., Lubinski J., Lynch H. T., Ghadirian P., Neuhausen S., Isaacs C., Weber B.
L., Horsman D., Rosen B., Foulkes W. D., Friedman E., Gershoni-Baruch R., Ainsworth
P., Daly M., Garber J., Olsson H., Sun P. and Narod S. A. Breast-feeding and the risk of
breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst
2004;96(14):1094-8.
31. Jogi A., Vallon-Christersson J., Holmquist L., Axelson H., Borg A. and Pahlman S.
Human neuroblastoma cells exposed to hypoxia: induction of genes associated with
growth, survival, and aggressive behavior. Exp Cell Res 2004;295(2):469-87.
32. Johannsdottir H. K., Johannesdottir G., Agnarsson B. A., Eerola H., Arason A.,
Johannsson O. T., Heikkila P., Egilsson V., Olsson H., Borg A., Nevanlinna H. and
3
Barkardottir R. B. Deletions on chromosome 4 in sporadic and BRCA mutated tumors and
association with pathological variables. Anticancer Res 2004;24(5A):2681-7.
33. Lahmann P. H., Gullberg B., Olsson H., Boeing H., Berglund G. and Lissner L. Birth
weight is associated with postmenopausal breast cancer risk in Swedish women. Br J
Cancer 2004;91(9):1666-8.
34. Landgren O., Bjorkholm M., Konradsen H. B., Soderqvist M., Nilsson B., Gustavsson A.,
Axdorph U., Kalin M. and Grimfors G. A prospective study on antibody response to
repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized
individuals with special reference to Hodgkin's lymphoma. J Intern Med
2004;255(6):664-73.
35. Link K., Moell C., Garwicz S., Cavallin-Stahl E., Bjork J., Thilen U., Ahren B. and
Erfurth E. M. Growth hormone deficiency predicts cardiovascular risk in young adults
treated for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab
2004;89(10):5003-12.
36. Loman N. [BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old
finding of the genetic mutation makes it now possible to prevent breast cancer].
Lakartidningen 2004;101(25):2172-7.
37. Malander S., Ridderheim M., Masback A., Loman N., Kristoffersson U., Olsson H.,
Nilbert M. and Borg A. One in 10 ovarian cancer patients carry germ line BRCA1 or
BRCA2 mutations. results of a prospective study in Southern Sweden. Eur J Cancer
2004;40(3):422-8.
38. Mattisson I., Wirfalt E., Wallstrom P., Gullberg B., Olsson H. and Berglund G. High fat
and alcohol intakes are risk factors of postmenopausal breast cancer: a prospective study
from the Malmo diet and cancer cohort. Int J Cancer 2004;110(4):589-97.
39. Mattisson I., Wirfalt E., Johansson U., Gullberg B., Olsson H. and Berglund G. Intakes of
plant foods, fibre and fat and risk of breast cancer--a prospective study in the Malmo Diet
and Cancer cohort. Br J Cancer 2004;90(1):122-7.
40. Mikkelsen T., Werner M. U., Lassen B. and Kehlet H. Pain and sensory dysfunction 6 to
12 months after inguinal herniotomy. Anesth Analg 2004;99(1):146-51.
41. Nielsen K., Ingvar C., Masback A., Westerdahl J., Borg A., Sandberg T., Jonsson N.,
Nagel J. and Olsson H. Melanoma and nonmelanoma skin cancer in patients with multiple
tumours--evidence for new syndromes in a population-based study. Br J Dermatol
2004;150(3):531-6.
42. Nielsen K., Ingvar C., Masback A., Westerdahl J., Borg A., Sandberg T., Jonsson N.,
Nagel J. and Olsson H. A familial syndromic association between cutaneous malignant
melanoma and neural system tumours: reply from authors. Br J Dermatol
2004;151(6):1279.
4
43. Nilbert M., Meza-Zepeda L., Francis P., Berner J., HM N., Fernebro E. and Myklebost O.
Lessons from genetic profiling in soft tissue sarcomas. Acta Orthop Scand 2004;Suppl
311(75):35-50.
44. Nilbert M. and Engellau J. Experiences from tissue microarray in soft tissue sarcomas.
Acta Orthop Scand Suppl 2004;75(311):29-34.
45. Nimeus E., Baldetorp B., Bendahl P. O., Rennstam K., Wennerberg J., Akervall J. and
Ferno M. Amplification of the cyclin D1 gene is associated with tumour subsite, DNA
non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck.
Oral Oncol 2004;40(6):624-9.
46. Obad S., Brunnstrom H., Vallon-Christersson J., Borg A., Drott K. and Gullberg U.
Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U937 cells. Oncogene 2004.
47. Olsson H. An updated review of the epidemiology of soft tissue sarcoma. Acta Orthop
Scand Suppl 2004;75(311):16-20.
48. Pedersen J. L., Lilleso J., Hammer N. A., Werner M. U., Holte K., Lacouture P. G. and
Kehlet H. Bupivacaine in microcapsules prolongs analgesia after subcutaneous infiltration
in humans: a dose-finding study. Anesth Analg 2004;99(3):912-8, table of contents.
49. Perkins F. M., Werner M. U., Persson F., Holte K., Jensen T. S. and Kehlet H.
Development and validation of a brief, descriptive Danish pain questionnaire (BDDPQ).
Acta Anaesthesiol Scand 2004;48(4):486-90.
50. Ringner M., Veerla S., Andersson S., Staaf J. and Hakkinen J. ACID: a database for
microarray clone information. Bioinformatics 2004;20(14):2305-6.
51. Rose C. Letter to the editor. Eur J Cancer 2004;40(18):2859.
52. Rose C., Loman N., Killander F. and Kinhult S. Systemic therapy of metastatic breast
cancer in postmenopausal patients. In: Dowsett M. and Ingel J. N., eds. Endocrine
Therapy of Breast Cancer, 2004: 33-46 Chapter 3.
53. Stahl O., Eberhard J., Jepson K., Spano M., Cwikiel M., Cavallin-Stahl E. and Giwercman
A. The impact of testicular carcinoma and its treatment on sperm DNA integrity. Cancer
2004;100(6):1137-44.
54. Syrjakoski K., Kuukasjarvi T., Waltering K., Haraldsson K., Auvinen A., Borg A., Kainu
T., Kallioniemi O. P. and Koivisto P. A. BRCA2 mutations in 154 finnish male breast
cancer patients. Neoplasia 2004;6(5):541-5.
55. Thomassen M., Kruse T. A., Olsen K. E., Borg A. and Gerdes A. M. Loss of
heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast
carcinomas in a family with a germline BRCA2 mutation. Breast Cancer Res Treat
2004;87(3):273-276.
5
56. Wallin G., Lundell G. and Tennvall J. Anaplastic giant cell thyroid carcinoma. Scand J
Surg 2004;93(4):272-7.
57. Werner M. U., Duun P. and Kehlet H. Prediction of postoperative pain by preoperative
nociceptive responses to heat stimulation. Anesthesiology 2004;100(1):115-9; discussion
5A.
58. Wirfalt E., Vessby B., Mattisson I., Gullberg B., Olsson H. and Berglund G. No relations
between breast cancer risk and fatty acids of erythrocyte membranes in postmenopausal
women of the Malmo Diet Cancer cohort (Sweden). Eur J Clin Nutr 2004;58(5):761-70.
THESIS
58. Engellau J. Prognostic factors in soft tissue sarcoma Tissue microarray for
immunostaining, the importance of whole-tumor sections and time-dependence: Lund,
2004.
59. Rennstam K. Molecular cytogenetics in sporadic breastcancer: Lund, 2004.
6
